Healthcare Holding B.V. Gilde Sells 20,034 Shares of Shoulder Innovations (NYSE:SI) Stock

Shoulder Innovations, Inc. (NYSE:SI) major shareholder Healthcare Holding B.V. Gilde sold 20,034 shares of Shoulder Innovations stock in a transaction that occurred on Friday, July 31st. The stock was sold at an average price of $22.73, for a total transaction of $455,372.82. Following the completion of the sale, the insider owned 2,332,203 shares of the company’s stock, valued at $53,010,974.19. This trade represents a 0.85% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Major shareholders that own 10% or more of a company’s stock are required to disclose their transactions with the SEC.

Healthcare Holding B.V. Gilde also recently made the following trade(s):

• On Thursday, July 30th, Healthcare Holding B.V. Gilde sold 28,245 shares of Shoulder Innovations stock. The shares were sold at an average price of $23.36, for a total value of $659,803.20.

Shoulder Innovations Stock Up 1.5%

Shares of SI stock opened at $22.72 on Wednesday. Shoulder Innovations, Inc. has a fifty-two week low of $10.92 and a fifty-two week high of $24.59. The firm has a market capitalization of $471.13 million and a PE ratio of -0.14. The company has a debt-to-equity ratio of 0.11, a quick ratio of 10.04 and a current ratio of 11.81. The stock’s 50-day simple moving average is $19.50 and its 200-day simple moving average is $15.92.

Shoulder Innovations (NYSE:SI) last released its earnings results on Wednesday, May 13th. The company reported ($0.41) EPS for the quarter, topping analysts’ consensus estimates of ($0.44) by $0.03. Shoulder Innovations had a negative return on equity of 35.11% and a negative net margin of 81.78%.The firm had revenue of $16.71 million during the quarter. Equities analysts expect that Shoulder Innovations, Inc. will post -1.67 earnings per share for the current year.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on the stock. UBS Group started coverage on shares of Shoulder Innovations in a research note on Tuesday, July 28th. They issued a “buy” rating and a $27.00 target price for the company. Weiss Ratings raised shares of Shoulder Innovations from a “sell (d-)” rating to a “sell (d)” rating in a report on Monday. Finally, Piper Sandler reiterated an “overweight” rating and issued a $19.00 price objective (up from $18.00) on shares of Shoulder Innovations in a research report on Friday, May 8th. Six research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $22.00.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the company. Rhumbline Advisers purchased a new position in Shoulder Innovations during the third quarter worth approximately $54,000. Vanguard Group Inc. acquired a new stake in shares of Shoulder Innovations in the 3rd quarter worth $1,836,000. Deerfield Management Company L.P. acquired a new stake in shares of Shoulder Innovations in the 3rd quarter worth $6,056,000. Bank of America Corp DE purchased a new position in shares of Shoulder Innovations during the 3rd quarter worth $322,000. Finally, Citadel Advisors LLC purchased a new position in shares of Shoulder Innovations during the 3rd quarter worth $628,000.

About Shoulder Innovations

Shoulder Innovations (NYSE:SI) is a medical device company focused on the design, development and commercialization of shoulder implant systems and related surgical instruments for orthopedic surgery. The company’s product portfolio includes modular shoulder prostheses, humeral and glenoid components, and instrumentation kits designed to facilitate both primary and revision shoulder arthroplasty procedures. Emphasizing a patient-centric approach, Shoulder Innovations works to offer implant solutions that aim to restore mobility and reduce post-operative complications.

In addition to its core implant offerings, Shoulder Innovations provides comprehensive clinical support and training programs for surgeons and operating room teams.